Please login to the form below

Not currently logged in
Email:
Password:

medicines access

This page shows the latest medicines access news and features for those working in and with pharma, biotech and healthcare.

Novartis reveals plans for a zero-profit COVID-19 drugs portfolio

Novartis reveals plans for a zero-profit COVID-19 drugs portfolio

The new initiative aims to help countries to access affordable medicines to treat the major symptoms of COVID-19, including inflammation and respiratory problems linked to the disease. ... Access to medicine can be a challenge for patients in low- and

Latest news

More from news
Approximately 4 fully matching, plus 439 partially matching documents found.

Latest Intelligence

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    disease. Is there a way to accelerate patient access to medicines for earlystage cancers in the interim? ... Jason Ward is Head of Haematology and Group Director, Strategy, Policy &Operations, Oncology Market Access and Pricing at AstraZeneca.

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    The access landscape is further complicated because many health technology assessment (HTA) methodologies are currently not geared up to evaluate these treatments. ... Yet a product only succeeds if patients can access it, and smooth market entry in AD.

  • BRIC markets BRIC markets

    The list enables the government to negotiate lower prices for medicines on the list in return for greater access to patients. ... Market access. Access strategies are also evolving. Initially multinational pharmaceutical companies entered BRIC markets by

  • Case study: Leading by example Case study: Leading by example

    The situation was compounded by a series of communications challenges. Media and political commentary highlighted the potential threats to the supply of life-saving medicines to the UK. ... Finally, the company has supported industry’s moves to

  • As the opioid crisis grabs the headlines, the search for safe treatments continues As the opioid crisis grabs the headlines, the search for safe treatments continues

    Indivior’s Gilles Picard charts a path to greater patient access and new therapies. ... But access to safer medicines has shown you can reduce mortality, HIV infection and relapse while also limiting misuse to a low percentage.

More from intelligence
Approximately 0 fully matching, plus 92 partially matching documents found.

Latest appointments

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... During his time at Pfizer, Maine also

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country. ... She will also collaborate with the operations and patient access team to ensure the medicines are accessible to as many appropriate

  • Inceptua Medicines Access appoints senior new-hires Inceptua Medicines Access appoints senior new-hires

    Multipharma’s new speciality business unit, Inceptua has appointed Ruth Rostron as its new senior project manager, a role that will see her focus on design and implementation of medicines access

  • Sandoz UK promotes Tim de Gavre to country head Sandoz UK promotes Tim de Gavre to country head

    As a company, Sandoz has an exciting portfolio of medicines and future product pipeline. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... He also brings experience form Boehringer Ingelheim, where he

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • EU Pharmaceutical Strategy Roadmap EU Pharmaceutical Strategy Roadmap

    The debates around access, availability (including shortages) and affordability of medicines are not new. ... The consultation focuses on the key themes of strategic autonomy and manufacturing of medicines, access to affordable medicines, innovation, and

  • Enabling market access through outcomes-based pricing

    Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines. ... In some cases focus on cost containment can compromise

  • The growing clinical importance of patient-reported outcomes (PROs)

    The characteristics of a well-developed PRO. Both the FDA and the European Medicines Agency (EMA) are showing interest in including PROs in their assessments. ... Soon, PRO instruments will help ensure the right patients can access medicines offering the

  • The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments

    On 9 July 2019, the World Health Organization (WHO) published the 21st edition of the EML, recommending the inclusion of 28 new medicines. ... The inclusion of innovative medicines in the WHO EML is an important step to help patients gain access to

  • Accession Accession

    Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices.

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics